Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Increased levels of carbonic anhydrase II in the developing Down syndrome brain.

Palminiello S, Kida E, Kaur K, Walus M, Wisniewski KE, Wierzba-Bobrowicz T, Rabe A, Albertini G, Golabek AA.

Brain Res. 2008 Jan 23;1190:193-205. Epub 2007 Nov 22.

PMID:
18083150
[PubMed - indexed for MEDLINE]
2.

Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down syndrome and Alzheimer's disease.

Vlkolinský R, Cairns N, Fountoulakis M, Lubec G.

Neurobiol Aging. 2001 Jul-Aug;22(4):547-53.

PMID:
11445254
[PubMed - indexed for MEDLINE]
3.

Carbonic anhydrase II in the developing and adult human brain.

Kida E, Palminiello S, Golabek AA, Walus M, Wierzba-Bobrowicz T, Rabe A, Albertini G, Wisniewski KE.

J Neuropathol Exp Neurol. 2006 Jul;65(7):664-74.

PMID:
16825953
[PubMed - indexed for MEDLINE]
4.

Upregulation of phosphorylated alphaB-crystallin in the brain of children and young adults with Down syndrome.

Palminiello S, Jarzabek K, Kaur K, Walus M, Rabe A, Albertini G, Golabek AA, Kida E.

Brain Res. 2009 May 1;1268:162-73. doi: 10.1016/j.brainres.2009.02.058. Epub 2009 Mar 9.

PMID:
19272359
[PubMed - indexed for MEDLINE]
5.

Oligodendrocytes express a normal phenotype in carbonic anhydrase II-deficient mice.

Ghandour MS, Skoff RP, Venta PJ, Tashian RE.

J Neurosci Res. 1989 Jun;23(2):180-90.

PMID:
2502636
[PubMed - indexed for MEDLINE]
6.

Carbonic anhydrase, 5'-nucleotidase, and 2',3'-cyclic nucleotide-3'-phosphodiesterase activities in oligodendrocytes, astrocytes, and neurons isolated from the brains of developing rats.

Snyder DS, Zimmerman TR Jr, Farooq M, Norton WT, Cammer W.

J Neurochem. 1983 Jan;40(1):120-7.

PMID:
6294243
[PubMed - indexed for MEDLINE]
8.

Selective tonicity-induced expression of the neutral amino-acid transporter SNAT2 in oligodendrocytes in rat brain following systemic hypertonicity.

Maallem S, Mutin M, González-González IM, Zafra F, Tappaz ML.

Neuroscience. 2008 Apr 22;153(1):95-107. doi: 10.1016/j.neuroscience.2008.01.047. Epub 2008 Feb 8.

PMID:
18358621
[PubMed - indexed for MEDLINE]
9.

Expression of cystathionine beta-synthase, pyridoxal kinase, and ES1 protein homolog (mitochondrial precursor) in fetal Down syndrome brain.

Shin JH, Weitzdoerfer R, Fountoulakis M, Lubec G.

Neurochem Int. 2004 Jul;45(1):73-9.

PMID:
15082224
[PubMed - indexed for MEDLINE]
10.

Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

Kahlem P, Sultan M, Herwig R, Steinfath M, Balzereit D, Eppens B, Saran NG, Pletcher MT, South ST, Stetten G, Lehrach H, Reeves RH, Yaspo ML.

Genome Res. 2004 Jul;14(7):1258-67.

PMID:
15231742
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Developmental instability of the cerebellum and its relevance to Down syndrome.

Shapiro BL.

J Neural Transm Suppl. 2001;(61):11-34. Review.

PMID:
11771737
[PubMed - indexed for MEDLINE]
12.
13.

Ca2+-dependent permeability transition regulation in rat brain mitochondria by 2',3'-cyclic nucleotides and 2',3'-cyclic nucleotide 3'-phosphodiesterase.

Azarashvili T, Krestinina O, Galvita A, Grachev D, Baburina Y, Stricker R, Evtodienko Y, Reiser G.

Am J Physiol Cell Physiol. 2009 Jun;296(6):C1428-39. doi: 10.1152/ajpcell.00006.2009. Epub 2009 Apr 8.

PMID:
19357238
[PubMed - indexed for MEDLINE]
Free Article
14.

Carbonic anhydrase gene expression in CA II-deficient (Car2-/-) and CA IX-deficient (Car9-/-) mice.

Pan P, Leppilampi M, Pastorekova S, Pastorek J, Waheed A, Sly WS, Parkkila S.

J Physiol. 2006 Mar 1;571(Pt 2):319-27. Epub 2006 Jan 5.

PMID:
16396925
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS.

O'Leary DA, Pritchard MA, Xu D, Kola I, Hertzog PJ, Ristevski S.

Biochim Biophys Acta. 2004 Dec 24;1739(1):81-7.

PMID:
15607120
[PubMed - indexed for MEDLINE]
Free Article
16.

Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.

Belichenko PV, Kleschevnikov AM, Salehi A, Epstein CJ, Mobley WC.

J Comp Neurol. 2007 Oct 1;504(4):329-45.

PMID:
17663443
[PubMed - indexed for MEDLINE]
17.

Gene expression variation in Down's syndrome mice allows prioritization of candidate genes.

Sultan M, Piccini I, Balzereit D, Herwig R, Saran NG, Lehrach H, Reeves RH, Yaspo ML.

Genome Biol. 2007;8(5):R91.

PMID:
17531092
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prenatal NAP+SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and gamma-aminobutyric acid receptors.

Vink J, Incerti M, Toso L, Roberson R, Abebe D, Spong CY.

Am J Obstet Gynecol. 2009 May;200(5):524.e1-4. doi: 10.1016/j.ajog.2009.01.052. Epub 2009 Mar 26.

PMID:
19327737
[PubMed - indexed for MEDLINE]
19.

Altered astrocyte calcium homeostasis and proliferation in theTs65Dn mouse, a model of Down syndrome.

Bambrick LL, Yarowsky PJ, Krueger BK.

J Neurosci Res. 2003 Jul 1;73(1):89-94.

PMID:
12815712
[PubMed - indexed for MEDLINE]
20.

Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.

Rachidi M, Lopes C.

Neurosci Res. 2007 Dec;59(4):349-69. Epub 2007 Aug 15. Review.

PMID:
17897742
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk